πŸ‡ΊπŸ‡Έ FDA
Patent

US 11020459

Factor VIII formulations

granted A61KA61K38/37A61K47/02

Quick answer

US patent 11020459 (Factor VIII formulations) held by UNIVERSITY OF CONNECTICUT expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/37, A61K47/02, A61K47/10, A61K47/18